A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a new study.
The study involved 53 men and women with an average age of 38. The participants were given a combination of several antiretroviral drugs known as Highly Active Anti-Retroviral Therapy (HAART) for one year. Researchers tested the participants’ cerebrospinal fluid before and after treatment to see if there were elevated levels of a particular biomarker for brain injury called neurofilament light protein.
The study found 21 people had high levels of the protein, suggestive of brain damage, at the beginning of treatment. But after three months of taking HAART, those high levels of protein fell to normal levels in nearly half of the patients. After one year of treatment, only four people still had high levels of this particular biomarker for brain damage.
In addition, for the 32 patients who had normal levels of the protein at the beginning of the study, all but one remained normal at follow-up.
“This type of treatment appears to halt the neurodegenerative process caused by HIV,” said study author Åsa Mellgren, MD, PhD, with the Clinic of Infectious Diseases SÄS in Borås, Sweden, and the Sahlgrenska Academy at Göteborg University in Göteborg, Sweden. “This study confirms that neurofilament light protein serves as a useful marker in monitoring brain injury in people with HIV and in evaluating the effectiveness of HAART.”
The study also found nine of the 21 people with high levels of the protein had dementia as a result of AIDS and their levels of the protein were significantly higher than those without dementia at the beginning of the study. “But four of these people with dementia did not see their levels return to normal by the end of the study,” said Mellgren. “It’s possible these levels may have reached normal limits if the study had been longer.”
Mellgren says a larger, longitudinal study of the protein is needed that includes more extensive neurological measures, including cognitive testing of the study participants.
The study was supported by grants from the National Institutes of Health, Göteborg University, and Research Foundation of Swedish Physicians against AIDS.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Part I: Bee Deaths Mystery Solved? Neonicotinoids (Neonics) May Actually Help Bee Health
- Chronic Pain Isn't All In The Brain
- Smoking, Drinking And Eating: It's Not About Your Freedom
- Violence, Sex And Taboo: The Original Brothers Grimm Fairy Tales Back In Print
- Part II: Bee Deaths And CCD - Flawed Chensheng Lu Harvard Studies Endanger Bees
- On integrating out short-distance physics
- Is The Micropower Revolution Here?
- "There is no question they were created to cater to universities and are staffed by people from..."
- "And my second link should be not a copy of the first, but this: http://www.nature.com/news/half..."
- "Recently I saw The Conversation remove/censor legitimate comments arguing against an article written..."
- tags because there's no testing..." href="/robert_inventor/why_we_cant_backup_earth_on_mars_the_moon_or_anywhere_else_in_our_solar_system-148364#comment-182183">"Robert, you might want to reformat my post. I intended to highlight only the headlines for easy..."
- "My only complaint with good thinkers and writers has hither always been that they should produce..."
Books By Writers Here